Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

The Medipattern Corporation (TSX VENTURE:MKI - News), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce that partner SonoCine Inc. ("SonoCine") successfully demonstrated automated whole breast ultrasound in breast screening applications in China. In direct comparison between a doctor performing breast scans via traditional 2D frozen frame imaging and automated whole breast ultrasound, the whole breast method found more pathology. Medipattern writes the software that powers the SonoCine viewer building 3D images of the breast and supplies its B-CAD(TM) computer aided detection product to the SonoCine product line.

"The traditional method of free hand scanning a patient allows for some variance in coverage as the physician scans. SonoCine takes the guess work out of scanning by automating the process and completely mapping each breast. A missed area of 5 mm in scanning by hand can result in missing a 5 mm cancer," says Dr. Kevin Kelly, President and founder of SonoCine. "Through Medipattern's software, we were able to identify correctly a rare case of male breast cancer which had previously been dismissed twice as benign."

"Breast cancer is one of the fastest rising threats to the people of China. We are convinced that the only way to combat breast cancer is through early detection. But we have been hampered by the very dense breast type common in the Chinese population. We know that ultrasound as a technology is capable of penetrating this dense tissue, but ultrasound is also known to be subject to operator variance," comments Dr. Tang, Director of Ultrasound at the People's Liberation Army (PLA) 301 hospital in China, China's largest hospital and research center. "The SonoCine technique packaged with the Medipattern whole breast viewing software and Medipattern's B-CAD computer aided detection provides a very compelling answer to the concerns raised by screening with breast ultrasound. B-CAD has been shown to increase the diagnostic accuracy of a single reader. SonoCine powered by Medipattern has been shown to fully capture all of the information required to make a decision. This is a very economically feasible answer to providing early detection for the population of China."

"Dr. Kelly is an experienced breast imaging radiologist who was concerned that ultrasound had been bypassed as a solution for screening dense breast tissue. He invented the procedure and created a company to tackle the problem. Ultrasound is cost effective, does not introduce the patient to radiation, and ultrasound provides great imaging especially in dense tissue," comments Jeff Collins, president and founder of The Medipattern Corporation. "Medipattern was pleased to introduce SonoCine to its partner reseller, Beijing Eastwide and researchers at the PLA301 in China to show them that ultrasound can be effective in screening for breast cancer. B-CAD has been submitted for SFDA in China and we expect sales of B-CAD to commence once final approval from China's State Food and Drug Administration is obtained."

Source: http://www.medipattern.com/investors_news.aspx